Searched for
ANTIBIOTIC RESISTANCE
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
Aegis Logistics shares rally 4% as Q4 profit rises 45% YoY; Board recommends dividendAegis Logistics shares rose sharply after the company reported a 45% year-on-year rise in Q4 FY26 consolidated net profit to Rs 413 crore, ...
Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
Aldi pizza salmonella alert: Check full list of items in warning circularAldi pizza salmonella: At least 34 people in 13 states have been sickened with salmonella poisoning traced to contact with backyard poultry...
Why Your Kitchen Sponge Might Be Making Everything Smell WorseYour kitchen sponge, a cleaning essential, harbors billions of bacteria. Research reveals these porous tools become microbial hotspots, bre...
India's protein boom: Growth, risks & need for sustainable sourcingIndia's appetite for protein is on the rise, opening doors for food enterprises seeking growth. However, this expansion is not without chal...
Common weedkiller in Australian homes linked to ‘superbug’ threat, study warns of rising antimicrobial resistance beyond antibiotic misuseA common weedkiller used widely in Australia may be contributing to the rise of superbugs. New research suggests this chemical can drive ba...
Govt asks doctors, pharmacists to mention reasons for prescribing antibioticsThe Union Health Ministry has called for doctors to mention the indication and reason for prescribing antibiotics. This is in response to t...
Taking antibiotics for cough & cold can become life threatening, warn expertsMedical experts at King George’s Medical University (KGMU) Lucknow have raised concerns about the indiscriminate use of antibiotics for min...
- India among hotspots of antibiotic resistance in animals: Study
India's antibiotics usage witnessed maximum rise among LMICs in 15 years: StudyDoctors and experts have warned that with the prolonged use of antibiotics, many patients have become anti-antibiotic that even the primary...